Sign In
Buy SDZNY
$79.34
-0.468 (-0.586%)
At Close: Jun 03, 2026
Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities
02:00am, Wednesday, 05'th Nov 2025
Group revenues of € 535.1 m ((7.1)%); Discovery & Preclinical Development segment ("D&PD", (12.3)%) still sees soft demand;Just - Evotec Biologics ("JEB"; +11.3%) above-expectation; further accelera
Transaction showcases Evotec's unique capability enabling customers to produce biologics faster and at lower costs through its continuous manufacturing technology Accelerated implementation of strateg
SDZNY vs. STVN: Which Stock Is the Better Value Option?
01:51pm, Friday, 31'st Oct 2025
Investors interested in Medical - Drugs stocks are likely familiar with Sandoz Group AG Sponsored ADR (SDZNY) and Stevanato Group (STVN). But which of these two companies is the best option for those
Sandoz Group AG (SDZNY) Q3 2025 Sales Call Transcript
07:36am, Thursday, 30'th Oct 2025
Sandoz Group AG (OTCQX:SDZNY) Q3 2025 Sales Call October 30, 2025 4:00 AM EDT Company Participants Craig Marks - Head of Investor Relations Richard Saynor - Chief Executive Officer Remco Steenbergen -
My Top 5 Biotech Stocks Big Pharma Could Buy Next
01:29pm, Monday, 06'th Oct 2025
While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
12:40pm, Monday, 29'th Sep 2025
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Sandoz Group AG Sponsored ADR (SDZNY) and Zoetis (ZTS). But which of these two stocks is more attractive t
Sandoz launches affordable iron sucrose injection for treatment of iron deficiency anemia in patients with chronic kidney disease in US
04:15pm, Wednesday, 24'th Sep 2025
PRINCETON, N.J.--(BUSINESS WIRE)--Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today announced the US launch of its generic iron sucrose injection following recent appro
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
12:40pm, Friday, 12'th Sep 2025
Investors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz Group AG Sponsored ADR (SDZNY) or Zoetis (ZTS). But which of these two stocks is more attractive to valu
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 27'th Aug 2025
Investors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz Group AG Sponsored ADR (SDZNY) or Zoetis (ZTS). But which of these two companies is the best option for
Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
01:00am, Tuesday, 12'th Aug 2025
MEDIA RELEASE Sandoz signs 10-year virtual PPA with Elawan Energy for new 150 MW solar projects in Spain Will cover nearly 90% of electricity demand for European operations Concrete step to support gl
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
12:41pm, Monday, 11'th Aug 2025
Investors with an interest in Medical - Drugs stocks have likely encountered both Sandoz Group AG Sponsored ADR (SDZNY) and Zoetis (ZTS). But which of these two companies is the best option for those
Sandoz Group AG (SDZNY) Q2 2025 Earnings Call Transcript
11:15am, Thursday, 07'th Aug 2025
Sandoz Group AG (OTCQX:SDZNY) Q2 2025 Earnings Conference Call August 7, 2025 3:00 AM ET Company Participants Craig Marks - Corporate Participant Head, IR - Corporate Participant Remco J. Steenbergen
Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
01:00am, Thursday, 07'th Aug 2025
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Basel, August 7, 2025 – Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in generic and biosimilar medicines,
Sandoz targets 70% price cut for weight-loss drugs in Canada, FT reports
12:14am, Tuesday, 05'th Aug 2025
Swiss generic drug manufacturer Sandoz plans to introduce unbranded weight-loss drugs in Canada at up to a 70% discount compared to branded versions when patents begin expiring next year, CEO Richard
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site
01:45am, Wednesday, 30'th Jul 2025
HAMBURG, DE / ACCESS Newswire / July 30, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces the signing of a non-bin
